Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
? Peripheral neuropathy
? Entrapment neuropathy
? Trigeminal neuralgia
? Phantom limb pain
? Post herpetic neuralgia (PHN)
? Post traumatic neuropathy
PART 6. MARKET BREAKDOWN BY INDICATION
? Diabetic neuropathy
? Spinal stenosis
? Chemotherapy
? Others
PART 7. MARKET BREAKDOWN BY DIAGNOSIS
? Imaging
? Blood tests
? Physical examination
PART 8. MARKET BREAKDOWN BY TREATMENT
? Medication
? Multimodal therapy
PART 9. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL
? Drug store
? Online
? Others
PART 10. MARKET BREAKDOWN BY END USER
? Hospital
? Clinic
? Research center
? Others
PART 11. MARKET BREAKDOWN BY REGION
? North America
? Europe
? Asia-Pacific
? MEA (Middle East and Africa)
? Latin America
PART 12. KEY COMPANIES
? Abbott Laboratories
? AstraZeneca plc
? Baxter International Inc.
? Eli Lilly and Company
? GSK plc
? Johnson & Johnson
? Pfizer Inc.
? Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER